Blog

CMS prior authorization rule finally crosses the finish line

CMS recently finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F). Review some of the key changes CMS made to their original proposal, how changes impact requirements for payers and providers, and how Redox can help them reach compliance.

Redox provides access to 17,000 active Carequality participants

Redox, the leading interoperability platform for healthcare data exchange, today announced that as a…

Redox virtual care customers grow by 46 percent in four…

Remedy and other providers adjust to rising demand for virtual care via the Redox Rapid Deployment Model MADISON,…

The Redox Podcast 24: The digital episode of care with…

It’s an honor to have Bronwyn Spira, CEO of Force Therapeutics, on the show today.

Vonage partners with Redox to power health record interoperability

Partnership enables safe, anywhere-access to personal and real-time medical care Holmdel, NJ (June 30, 2020) – Vonage (Nasdaq:…

The Redox Podcast 23: Preventing sepsis with Luminare’s Dr. Sarma…

Dr. Sarma Velamuri is an Internal Medicine doc, hospitalist, sepsis expert, and co-founder and CEO of Luminare, a…

The Redox Podcast 22: COVID’s impact on digital health

I have some sad news to share. On Tuesday, we had to let 44 Redoxers go. That…

Redox and Curative partner to connect COVID-19 test results to…

Patient Data Integration Helps Inform Policies for Contact Tracing and Phased Openings MADISON, WI – June 15, 2020…

The Redox Podcast 21: The economics of a healthcare recovery…

Professor James Robinson is a highly-regarded expert on healthcare economics and policy. He is currently a Professor…

The Redox Podcast 20: Powered by battery with Redox CEO…

Redox CEO Luke Bonney was the featured guest on this week’s episode of Battery Venture’s “Powered…

Diversity and belonging at Redox after Covid-19

At the beginning of March this year, we shared our 2020 Diversity goals and introduced our Belonging Program…

Blog Categories

Stay in the know! Subscribe to our newsletter.